Rong, Haojing

Physiologically Based Pharmacokinetic Model Qualification and Reporting Procedures for Regulatory Submissions: A Consortium Perspective

Shebley, M., Sandhu, P., Emami Riedmaier, A., Jamei, M., Narayanan, R., Patel, A., Peters, S. A., Reddy, V. P., Zheng, M., de Zwart, L., et al. (2018) · Clinical Pharmacology & Therapeutics

Pharmaceutical studies and practicesStatistical Methods in Clinical Trials

Cited by 395

A First-in-Class STAT3 Degrader KT-333 in Development for Treatment of Hematologic Cancers

Liu, P. C., Dixit, V., Mayo, M., Dey, J., Yuan, K., Karnik, R., Walther, D., Shi, Y., Sharma, K., Rong, H., et al. (2021) · Blood

Protein Degradation and InhibitorsCytokine Signaling Pathways and Interactions

Cited by 26